Announced ahead of the International AIDS Society Conference on HIV Science in Mexico City, the new study will evaluate an investigational vaccine regimen in eight countries around the world for its ability to protect people from HIV infection.
As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.
Check out this infographic breakdown of the company’s second-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
A new World Health Organization prequalification for mebendazole means the company can reach even more young people with intestinal worm infections around the globe.
Sharon Chan, head of the first Johnson & Johnson Innovation, JLABS, in Asia, gives us a tour of the exciting new incubator that's designed to help entrepreneurs turn great ideas into great products.
In time for summer, we went to the pros—a dermatologist, a marine biologist and a skincare scientist—to get the latest study-backed news you need to know.
Ever wonder what's in the mouthwash, lotion or shampoo you use? Kurt Reynertson knows everything there is to know about the ingredients in the company's consumer products—and the measures Johnson & Johnson takes to keep you safe.
From the creation of sterile surgical sutures in 1887 to the debut of the first water-resistant sunscreen in 1976, these products were some of the most significant inventions of their time.
-
What You're Talking About
-
Fact
Can you name three diseases that run in family trees? Get the answer—and find out how to reduce your risk.
Recent Johnson & Johnson Initiatives in the Spotlight
Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
